Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
申请人:Ligand Pharmaceuticals Incorporated
公开号:US20020183314A1
公开(公告)日:2002-12-05
Novel non-steroidal tricyclic quinolinone and tricyclic quinoline compounds and compositions that are agonists, partial agonists and/or antagonists for androgen receptors (AR), their preparation and their uses are described.